Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe and Simvastatin vs Atorvastatin in Hypercholesterolemia
NCT00092716Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- May 2002
- Primary completion
- Apr 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of ezetimibe in hypercholesterolemia (2 arms), sponsored by Organon & Co. Primary endpoint: Reduction in Low Density Lipoprotein Cholesterol at 6 weeks. Started May 2002; status: completed.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00092716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092716.